[DPHARMA] QoQ Annualized Quarter Result on 31-Mar-2014 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
20-May-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
31-Mar-2014 [#1]
Profit Trend
QoQ- 3.67%
YoY- 24.87%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
Revenue 176,961 167,916 162,236 161,980 162,405 155,561 151,652 10.80%
PBT 46,509 43,452 42,604 44,700 40,175 41,356 43,926 3.87%
Tax 0 -10,685 -10,820 -11,240 -7,900 -9,122 -9,150 -
NP 46,509 32,766 31,784 33,460 32,275 32,233 34,776 21.32%
-
NP to SH 35,271 32,766 31,784 33,460 32,275 32,233 34,776 0.94%
-
Tax Rate 0.00% 24.59% 25.40% 25.15% 19.66% 22.06% 20.83% -
Total Cost 130,452 135,149 130,452 128,520 130,130 123,328 116,876 7.57%
-
Net Worth 192,942 187,436 179,045 190,050 181,850 179,125 187,340 1.97%
Dividend
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
Div 25,679 7,404 11,103 - 24,293 - 11,101 74.64%
Div Payout % 72.81% 22.60% 34.93% - 75.27% - 31.92% -
Equity
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
Net Worth 192,942 187,436 179,045 190,050 181,850 179,125 187,340 1.97%
NOSH 138,807 138,841 138,794 138,723 138,817 138,856 138,770 0.01%
Ratio Analysis
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
NP Margin 26.28% 19.51% 19.59% 20.66% 19.87% 20.72% 22.93% -
ROE 18.28% 17.48% 17.75% 17.61% 17.75% 17.99% 18.56% -
Per Share
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
RPS 127.49 120.94 116.89 116.77 116.99 112.03 109.28 10.79%
EPS 25.41 23.60 22.90 24.12 23.25 23.21 25.06 0.92%
DPS 18.50 5.33 8.00 0.00 17.50 0.00 8.00 74.60%
NAPS 1.39 1.35 1.29 1.37 1.31 1.29 1.35 1.96%
Adjusted Per Share Value based on latest NOSH - 138,723
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
RPS 18.38 17.44 16.85 16.83 16.87 16.16 15.75 10.81%
EPS 3.66 3.40 3.30 3.48 3.35 3.35 3.61 0.91%
DPS 2.67 0.77 1.15 0.00 2.52 0.00 1.15 75.06%
NAPS 0.2004 0.1947 0.186 0.1974 0.1889 0.1861 0.1946 1.97%
Price Multiplier on Financial Quarter End Date
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
Date 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 28/06/13 -
Price 2.50 3.17 2.97 3.03 2.58 2.55 2.38 -
P/RPS 1.96 2.62 2.54 2.59 2.21 2.28 2.18 -6.82%
P/EPS 9.84 13.43 12.97 12.56 11.10 10.99 9.50 2.36%
EY 10.16 7.44 7.71 7.96 9.01 9.10 10.53 -2.35%
DY 7.40 1.68 2.69 0.00 6.78 0.00 3.36 69.03%
P/NAPS 1.80 2.35 2.30 2.21 1.97 1.98 1.76 1.50%
Price Multiplier on Announcement Date
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
Date 24/02/15 21/11/14 26/08/14 20/05/14 26/02/14 19/11/13 28/08/13 -
Price 2.92 3.01 3.37 3.09 2.60 2.56 2.44 -
P/RPS 2.29 2.49 2.88 2.65 2.22 2.29 2.23 1.78%
P/EPS 11.49 12.75 14.72 12.81 11.18 11.03 9.74 11.61%
EY 8.70 7.84 6.80 7.81 8.94 9.07 10.27 -10.44%
DY 6.34 1.77 2.37 0.00 6.73 0.00 3.28 54.98%
P/NAPS 2.10 2.23 2.61 2.26 1.98 1.98 1.81 10.38%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment